Description
Differentiates a Type I from Type II deficiency
Anti Thrombin III
Differentiates a Type I from Type II deficiency
TAT: 3 days
Specimen Type: Plasma
Hematology Single Test
Other Tests
-
60%
Absolute Eosinophil Count
Absolute eosinophil count is increased in allergic or atopic disease, infectious disorders (including parasites), medications, immunologic reactions, skin disorders, pulmonary syndromes, rheumatologic diseases, myeloproliferative neoplasms and secondary to other malignancies.
Absolute Eosinophil Count
Absolute eosinophil count is increased in allergic or atopic disease, infectious disorders (including parasites), medications, immunologic reactions, skin disorders, pulmonary syndromes, rheumatologic diseases, myeloproliferative neoplasms and secondary to other malignancies.
-
240%
Complete Blood Count(CBC) – Advanced
Blood count
-
209%
Bethesda Assay (Quantitative Factor VIII Inhibitor)
Factor VIII inhibitors are IgG antibodies which can occur in alloimmunised patients with Congenital Factor VIII deficiency or as autoantibodies.
Bethesda Assay (Quantitative Factor VIII Inhibitor)
Factor VIII inhibitors are IgG antibodies which can occur in alloimmunised patients with Congenital Factor VIII deficiency or as autoantibodies.
-
83%
Activated Partial Thromboplastin Time (APTT)
APTT measures intrinsic and common pathways of the coagulation cascade. Prolonged APTT may be caused by heparin and other anticoagulants, factor deficiencies or inhibitors such as lupus anticoagulants
Activated Partial Thromboplastin Time (APTT)
APTT measures intrinsic and common pathways of the coagulation cascade. Prolonged APTT may be caused by heparin and other anticoagulants, factor deficiencies or inhibitors such as lupus anticoagulants
Reviews
There are no reviews yet.